The DOI matches its Crossref record; 188 of the 188 references it cites were found in a registry or an index.
The Role of PGC-1α and Mitochondrial Biogenesis in Kidney Diseases
Open accessAbstract
Chronic kidney disease (CKD) is one of the fastest growing causes of death worldwide, emphasizing the need to develop novel therapeutic approaches. CKD predisposes to acute kidney injury (AKI) and AKI favors CKD progression. Mitochondrial derangements are common features of both AKI and CKD and mitochondria-targeting therapies are under study as nephroprotective agents. PGC-1α is a master regulator of mitochondrial biogenesis and an attractive therapeutic target. Low PGC-1α levels and decreased transcription of its gene targets have been observed in both preclinical AKI (nephrotoxic, endotoxemia, and ischemia-reperfusion) and in experimental and human CKD, most notably diabetic nephropathy. In mice, PGC-1α deficiency was associated with subclinical CKD and predisposition to AKI while PGC-1α overexpression in tubular cells protected from AKI of diverse causes. Several therapeutic strategies may increase kidney PGC-1α activity and have been successfully tested in animal models. These include AMP-activated protein kinase (AMPK) activators, phosphodiesterase (PDE) inhibitors, and anti-TWEAK antibodies. In conclusion, low PGC-1α activity appears to be a common feature of AKI and CKD and recent characterization of nephroprotective approaches that increase PGC-1α activity may pave the way for nephroprotective strategies potentially effective in both AKI and CKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
Webster, A. C., Nagler, E. V., Morton, R. L., & Masson, P. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32064-5 · Cited by 3,842
Foreman, K. J., Marquez, N., Dolgert, A., Fukutaki, K., Fullman, N., McGaughey, M., Pletcher, M. A., Smith, A. E., Tang, K., Yuan, C.-W., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31694-5 · Cited by 2,994
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
Farrell, G. C., & Larter, C. Z. (2006) · Hepatology · doi:10.1002/hep.20973 · Cited by 2,414
The Role of Mitochondria in Apoptosis
Wang, C., & Youle, R. J. (2009) · Annual Review of Genetics · doi:10.1146/annurev-genet-102108-134850 · Cited by 1,987
Effect of urinary extracts from salt-loaded man on urinary sodium excretion by the rat
Brown, P. R., Koutsaimanis, K. G., & de Wardener, H. E. (1972) · Kidney International · doi:10.1038/ki.1972.62 · Cited by 1,729
Kang, H. M., Ahn, S. H., Choi, P., Ko, Y.-A., Han, S. H., Chinga, F., Park, A. S. D., Tao, J., Sharma, K., Pullman, J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3762 · Cited by 1,555
Peerapornratana, S., Manrique-Caballero, C. L., Gómez, H., & Kellum, J. A. (2019) · Kidney International · doi:10.1016/j.kint.2019.05.026 · Cited by 1,471
CREB regulates hepatic gluconeogenesis through the coactivator PGC-1
Herzig, S., Long, F., Jhala, U. S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Schutz, G., Yoon, C., Puigserver, P., et al. (2001) · Nature · doi:10.1038/35093131 · Cited by 1,440
PGC-1 coactivators: inducible regulators of energy metabolism in health and disease
Finck, B. N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27794 · Cited by 1,432
Mitochondrial energetics in the kidney
Bhargava, P., & Schnellmann, R. G. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.107 · Cited by 1,334
Defects in Adaptive Energy Metabolism with CNS-Linked Hyperactivity in PGC-1α Null Mice
Lin, J., Wu, P.-H., Tarr, P. T., Lindenberg, K. S., St-Pierre, J., Zhang, C.-Y., Mootha, V. K., Jäger, S., Vianna, C. R., Reznick, R. M., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.013 · Cited by 1,162
Acute kidney injury: an increasing global concern
Lameire, N. H., Bagga, A., Cruz, D., De Maeseneer, J., Endre, Z., Kellum, J. A., Liu, K. D., Mehta, R. L., Pannu, N., Van Biesen, W., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60647-9 · Cited by 1,001
Sepsis associated acute kidney injury
Poston, J. T., & Koyner, J. L. (2019) · BMJ · doi:10.1136/bmj.k4891 · Cited by 818
Failed Tubule Recovery, AKI-CKD Transition, and Kidney Disease Progression
Venkatachalam, M. A., Weinberg, J. M., Kriz, W., & Bidani, A. K. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015010006 · Cited by 744
Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models
Brooks, C., Wei, Q., Cho, S.-G., & Dong, Z. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37829 · Cited by 735
Kong, X., Wang, R., Xue, Y., Liu, X., Zhang, H., Chen, Y., Fang, F., & Chang, Y. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011707 · Cited by 718
Cisplatin nephrotoxicity: a review of the literature
Manohar, S., & Leung, N. (2018) · Journal of Nephrology · doi:10.1007/s40620-017-0392-z · Cited by 636
MicroRNA-21 Promotes Fibrosis of the Kidney by Silencing Metabolic Pathways
Chau, B. N., Xin, C., Hartner, J., Ren, S., Castano, A. P., Linn, G., Li, J., Tran, P. T., Kaimal, V., Huang, X., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003205 · Cited by 587
Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease
Sharma, K., Karl, B., Mathew, A. V., Gangoiti, J. A., Wassel, C. L., Saito, R., Pu, M., Sharma, S., You, Y.-H., Wang, L., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013020126 · Cited by 571
Xiao, L., Xu, X., Zhang, F., Wang, M., Xu, Y., Tang, D., Wang, J., Qin, Y., Liu, Y., Tang, C., et al. (2017) · Redox Biology · doi:10.1016/j.redox.2016.12.022 · Cited by 569
Rhee, J., Inoue, Y., Yoon, J. C., Puigserver, P., Fan, M., Gonzalez, F. J., & Spiegelman, B. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730870100 · Cited by 567
Ferroptosis, but Not Necroptosis, Is Important in Nephrotoxic Folic Acid–Induced AKI
Martin-Sanchez, D., Ruiz-Andres, O., Poveda, J., Carrasco, S., Cannata-Ortiz, P., Sanchez-Niño, M. D., Ruiz Ortega, M., Egido, J., Linkermann, A., Ortiz, A., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015121376 · Cited by 564
Self-citationLinkermann, A., Chen, G., Dong, G., Kunzendorf, U., Krautwald, S., & Dong, Z. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014030262 · Cited by 563
PGC-1α regulates the mitochondrial antioxidant defense system in vascular endothelial cells
VALLE, I., ALVAREZBARRIENTOS, A., ARZA, E., LAMAS, S., & MONSALVE, M. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.01.026 · Cited by 556
Self-citationPGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3
Koo, S.-H., Satoh, H., Herzig, S., Lee, C.-H., Hedrick, S., Kulkarni, R., Evans, R. M., Olefsky, J., & Montminy, M. (2004) · Nature Medicine · doi:10.1038/nm1044 · Cited by 550
PGC1α drives NAD biosynthesis linking oxidative metabolism to renal protection
Tran, M. T., Zsengeller, Z. K., Berg, A. H., Khankin, E. V., Bhasin, M. K., Kim, W., Clish, C. B., Stillman, I. E., Karumanchi, S. A., Rhee, E. P., et al. (2016) · Nature · doi:10.1038/nature17184 · Cited by 541
Mechanisms of Cardiac and Renal Dysfunction in Patients Dying of Sepsis
Takasu, O., Gaut, J. P., Watanabe, E., To, K., Fagley, R. E., Sato, B., Jarman, S., Efimov, I. R., Janks, D. L., Srivastava, A., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201211-1983oc · Cited by 514
PGC-1α promotes recovery after acute kidney injury during systemic inflammation in mice
Tran, M., Tam, D., Bardia, A., Bhasin, M., Rowe, G. C., Kher, A., Zsengeller, Z. K., Akhavan-Sharif, M. R., Khankin, E. V., Saintgeniez, M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci58662 · Cited by 499
Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion
Ling, C., Del Guerra, S., Lupi, R., Rönn, T., Granhall, C., Luthman, H., Masiello, P., Marchetti, P., Groop, L., & Del Prato, S. (2008) · Diabetologia · doi:10.1007/s00125-007-0916-5 · Cited by 495 · cited 1×
“Thus, Gly482Ser, the most common PPARGC1A polymorphism, is associated with Type 2 DM (T2DM), but results in decreased PGC‐1α mRNA levels and insulin secretion [52] and insulin resistance [53].”
BackgroundQi, W., Keenan, H. A., Li, Q., Ishikado, A., Kannt, A., Sadowski, T., Yorek, M. A., Wu, I.-H., Lockhart, S., Coppey, L. J., et al. (2017) · Nature Medicine · doi:10.1038/nm.4328 · Cited by 479
NAFLD as a driver of chronic kidney disease
Byrne, C. D., & Targher, G. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.01.013 · Cited by 449
The hallmarks of mitochondrial dysfunction in chronic kidney disease
Galvan, D. L., Green, N. H., & Danesh, F. R. (2017) · Kidney International · doi:10.1016/j.kint.2017.05.034 · Cited by 447 · cited 1×
“More recent strategies are aimed at restoring mitochondrial metabolism, redox state, and dynamics, as well as enhancing biogenesis [131,132].”
MethodZoccali, C., Vanholder, R., Massy, Z. A., Ortiz, A., Sarafidis, P., Dekker, F. W., Fliser, D., Fouque, D., Heine, G. H., Jager, K. J., et al. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.52 · Cited by 444
Self-citationKramer, A., Pippias, M., Noordzij, M., Stel, V. S., Afentakis, N., Ambühl, P. M., Andrusev, A. M., Fuster, E. A., Arribas Monzón, F. E., Åsberg, A., et al. (2018) · Clinical Kidney Journal · doi:10.1093/ckj/sfx149 · Cited by 411
Villena, J. A. (2015) · The FEBS Journal · doi:10.1111/febs.13175 · Cited by 405
Sirtuin 3–dependent mitochondrial dynamic improvements protect against acute kidney injury
Morigi, M., Perico, L., Rota, C., Longaretti, L., Conti, S., Rottoli, D., Novelli, R., Remuzzi, G., & Benigni, A. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77632 · Cited by 403
Update on ischemia-reperfusion injury in kidney transplantation: Pathogenesis and treatment
Salvadori, M., Rosso, G., & Bertoni, E. (2015) · World Journal of Transplantation · doi:10.5500/wjt.v5.i2.52 · Cited by 391
Long noncoding RNA Tug1 regulates mitochondrial bioenergetics in diabetic nephropathy
Long, J., Badal, S. S., Ye, Z., Wang, Y., Ayanga, B. A., Galvan, D. L., Green, N. H., Chang, B. H., Overbeek, P. A., & Danesh, F. R. (2016) · Journal of Clinical Investigation · doi:10.1172/jci87927 · Cited by 372
Histopathology of septic shock induced acute kidney injury: apoptosis and leukocytic infiltration
Lerolle, N., Nochy, D., Guérot, E., Bruneval, P., Fagon, J.-Y., Diehl, J.-L., & Hill, G. (2010) · Intensive Care Medicine · doi:10.1007/s00134-009-1723-x · Cited by 370
De novo NAD+ biosynthetic impairment in acute kidney injury in humans
Poyan Mehr, A., Tran, M. T., Ralto, K. M., Leaf, D. E., Washco, V., Messmer, J., Lerner, A., Kher, A., Kim, S. H., Khoury, C. C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0138-z · Cited by 370
Mitochondrial biogenesis in neurodegeneration
Li, P. A., Hou, X., & Hao, S. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24042 · Cited by 353
The Role of Acute Kidney Injury in Chronic Kidney Disease
Hsu, R. K., & Hsu, C.-Y. (2016) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2016.05.005 · Cited by 340
Cardiorenal Syndrome Revisited
Zannad, F., & Rossignol, P. (2018) · Circulation · doi:10.1161/circulationaha.117.028814 · Cited by 335
Santos, N. A. G., Catão, C. S., Martins, N. M., Curti, C., Bianchi, M. L. P., & Santos, A. C. (2007) · Archives of Toxicology · doi:10.1007/s00204-006-0173-2 · Cited by 327
Kim, M. Y., Lim, J. H., Youn, H. H., Hong, Y. A., Yang, K. S., Park, H. S., Chung, S., Koh, S. H., Shin, S. J., Choi, B. S., et al. (2013) · Diabetologia · doi:10.1007/s00125-012-2747-2 · Cited by 315
Mitochondria-Targeted Peptide Accelerates ATP Recovery and Reduces Ischemic Kidney Injury
Szeto, H. H., Liu, S., Soong, Y., Wu, D., Darrah, S. F., Cheng, F.-Y., Zhao, Z., Ganger, M., Tow, C. Y., & Seshan, S. V. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010080808 · Cited by 313
Miyashita, K., Itoh, H., Tsujimoto, H., Tamura, N., Fukunaga, Y., Sone, M., Yamahara, K., Taura, D., Inuzuka, M., Sonoyama, T., et al. (2009) · Diabetes · doi:10.2337/db09-0393 · Cited by 288 · cited 1×
“Moreover, natriuretic peptides also stimulate cGMP synthesis and promote PGC‐1α expression and mitochondrial biogenesis [36].”
BackgroundZhan, M., Usman, I. M., Sun, L., & Kanwar, Y. S. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014050457 · Cited by 288
The fuel of respiration of rat kidney cortex
Weidemann, M. J., & Krebs, H. A. (1969) · Biochemical Journal · doi:10.1042/bj1120149 · Cited by 272
Mitochondria in Sepsis-Induced AKI
Sun, J., Zhang, J., Tian, J., Virzì, G. M., Digvijay, K., Cueto, L., Yin, Y., Rosner, M. H., & Ronco, C. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018111126 · Cited by 257
Persistent disruption of mitochondrial homeostasis after acute kidney injury
Funk, J. A., & Schnellmann, R. G. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00035.2011 · Cited by 255
Livingston, M. J., Wang, J., Zhou, J., Wu, G., Ganley, I. G., Hill, J. A., Yin, X.-M., & Dong, Z. (2019) · Autophagy · doi:10.1080/15548627.2019.1615822 · Cited by 254
Mechanisms of Renal Apoptosis in Health and Disease
Sanz, A. B., Santamari[Combining Acute Accent]a, B., Ruiz-Ortega, M., Egido, J., & Ortiz, A. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007121336 · Cited by 249
Self-citationUittenbogaard, M., & Chiaramello, A. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140305224906 · Cited by 239
Guan, Y., Wang, S.-R., Huang, X.-Z., Xie, Q.-H., Xu, Y.-Y., Shang, D., & Hao, C.-M. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016040385 · Cited by 238
Increased podocyte Sirtuin-1 function attenuates diabetic kidney injury
Hong, Q., Zhang, L., Das, B., Li, Z., Liu, B., Cai, G., Chen, X., Chuang, P. Y., He, J. C., & Lee, K. (2018) · Kidney International · doi:10.1016/j.kint.2017.12.008 · Cited by 222
FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity
Wang, X. X., Wang, D., Luo, Y., Myakala, K., Dobrinskikh, E., Rosenberg, A. Z., Levi, J., Kopp, J. B., Field, A., Hill, A., et al. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017020222 · Cited by 222
Mukhopadhyay, P., Horváth, B., Zsengellér, Z., Zielonka, J., Tanchian, G., Holovac, E., Kechrid, M., Patel, V., Stillman, I. E., Parikh, S. M., et al. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.11.001 · Cited by 209
Extended Criteria Donors in Liver Transplantation
Vodkin, I., & Kuo, A. (2017) · Clinics in Liver Disease · doi:10.1016/j.cld.2016.12.004 · Cited by 209
Mitochondrial dysfunction in diabetic kidney disease
Wei, P. Z., & Szeto, C. C. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.07.005 · Cited by 208
Plotnikov, E. Y., Kazachenko, A. V., Vyssokikh, M. Y., Vasileva, A. K., Tcvirkun, D. V., Isaev, N. K., Kirpatovsky, V. I., & Zorov, D. B. (2007) · Kidney International · doi:10.1038/sj.ki.5002568 · Cited by 207
Mitochondrial division and fusion in metabolism
Roy, M., Reddy, P. H., Iijima, M., & Sesaki, H. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2015.02.001 · Cited by 207
Finsterer, J. (2004) · European Journal of Neurology · doi:10.1046/j.1351-5101.2003.00728.x · Cited by 206
Prevention of diabetic nephropathy in Ins2+/−AkitaJ mice by the mitochondria-targeted therapy MitoQ
Chacko, B. K., Reily, C., Srivastava, A., Johnson, M. S., Ye, Y., Ulasova, E., Agarwal, A., Zinn, K. R., Murphy, M. P., Kalyanaraman, B., et al. (2010) · Biochemical Journal · doi:10.1042/bj20100308 · Cited by 204
ATP and the Regulation of Renal Cell Function
Soltoff, S. P. (1986) · Annual Review of Physiology · doi:10.1146/annurev.ph.48.030186.000301 · Cited by 202
An overview of Sirtuins as potential therapeutic target: Structure, function and modulators
Wang, Y., He, J., Liao, M., Hu, M., Li, W., Ouyang, H., Wang, X., Ye, T., Zhang, Y., & Ouyang, L. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.10.028 · Cited by 202
Mitochondrial Biogenesis as a Pharmacological Target: A New Approach to Acute and Chronic Diseases
Whitaker, R. M., Corum, D., Beeson, C. C., & Schnellmann, R. G. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103155 · Cited by 200
Pharmacologic Approaches to Improve Mitochondrial Function in AKI and CKD
Szeto, H. H. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017030247 · Cited by 199
Therapies for mitochondrial diseases and current clinical trials
El-Hattab, A. W., Zarante, A. M., Almannai, M., & Scaglia, F. (2017) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2017.09.009 · Cited by 188
Mitochondria: a therapeutic target in acute kidney injury
Ishimoto, Y., & Inagi, R. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv317 · Cited by 184
Mitochondrial Function and Disturbances in the Septic Kidney
Parikh, S. M., Yang, Y., He, L., Tang, C., Zhan, M., & Dong, Z. (2015) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2015.01.011 · Cited by 178
Histone lysine crotonylation during acute kidney injury in mice
Ruiz‐Andrés, O., Sánchez-Niño, M. D., Cannata‐Ortiz, P., Ruiz‐Ortega, M., Egido, J., Ortíz, A., & Sanz, A. B. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.024455 · Cited by 178
Self-citationDeficient Autophagy Results in Mitochondrial Dysfunction and FSGS
Kawakami, T., Gomez, I. G., Ren, S., Hudkins, K., Roach, A., Alpers, C. E., Shankland, S. J., D’Agati, V. D., & Duffield, J. S. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013111202 · Cited by 176
Patil, N. K., Parajuli, N., MacMillan-Crow, L. A., & Mayeux, P. R. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00643.2013 · Cited by 176
Brinkkoetter, P. T., Bork, T., Salou, S., Liang, W., Mizi, A., Özel, C., Koehler, S., Hagmann, H. H., Ising, C., Kuczkowski, A., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.04.012 · Cited by 175
Leigh Syndrome: Neuropathology and Pathogenesis
Lake, N. J., Bird, M. J., Isohanni, P., & Paetau, A. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000195 · Cited by 172
Wang, S., Wan, T., Ye, M., Qiu, Y., Pei, L., Jiang, R., Pang, N., Huang, Y., Liang, B., Ling, W., et al. (2018) · Redox Biology · doi:10.1016/j.redox.2018.04.006 · Cited by 171
Szeto, H. H., Liu, S., Soong, Y., Seshan, S. V., Cohen-Gould, L., Manichev, V., Feldman, L. C., & Gustafsson, T. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016070761 · Cited by 170
Kim, M. S., Sweeney, T. R., Shigenaga, J. K., Chui, L. G., Moser, A., Grunfeld, C., & Feingold, K. R. (2007) · Metabolism · doi:10.1016/j.metabol.2006.10.007 · Cited by 168
Signaling of Mitochondrial Biogenesis following Oxidant Injury
Rasbach, K. A., & Schnellmann, R. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608009200 · Cited by 168
Aharoni-Simon, M., Hahn-Obercyger, M., Pen, S., Madar, Z., & Tirosh, O. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.55 · Cited by 167
PGC-1α, glucose metabolism and type 2 diabetes mellitus
Wu, H., Deng, X., Shi, Y., Su, Y., Wei, J., & Duan, H. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0021 · Cited by 167
Borniquel, S., Valle, I., Cadenas, S., Lamas, S., & Monsalve, M. (2006) · The FASEB Journal · doi:10.1096/fj.05-5189fje · Cited by 166
Self-citationDecrease of mitochondrial DNA content and energy metabolism in renal cell carcinoma
Meierhofer, D. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh104 · Cited by 164
MicroRNA-15a positively regulates insulin synthesis by inhibiting uncoupling protein-2 expression
Sun, L.-L., Jiang, B.-G., Li, W.-T., Zou, J.-J., Shi, Y.-Q., & Liu, Z.-M. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.11.006 · Cited by 163
Emerging therapies for mitochondrial diseases
Hirano, M., Emmanuele, V., & Quinzii, C. M. (2018) · Essays in Biochemistry · doi:10.1042/ebc20170114 · Cited by 162
Zhou, D., Zhou, M., Wang, Z., Fu, Y., Jia, M., Wang, X., Liu, M., Zhang, Y., Sun, Y., Lu, Y., et al. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1754-3 · Cited by 162
Mitochondrial dysregulation and protection in cisplatin nephrotoxicity
Yuan, Y., Liu, H., Liu, F., & Dong, Z. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1239-1 · Cited by 161
PGC-1α Protects from Notch-Induced Kidney Fibrosis Development
Han, S. H., Wu, M.-Y., Nam, B. Y., Park, J. T., Yoo, T., Kang, S., Park, J., Chinga, F., Li, S., & Suszták, K. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017020130 · Cited by 159
Zhang, T., Chi, Y., Kang, Y., Lu, H., Niu, H., Liu, W., & Li, Y. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27306 · Cited by 159
Yuan, Y., Huang, S., Wang, W., Wang, Y., Zhang, P., Zhu, C., Ding, G., Liu, B., Yang, T., & Zhang, A. (2012) · Kidney International · doi:10.1038/ki.2012.188 · Cited by 158
TWEAK and RIPK1 mediate a second wave of cell death during AKI
Martín‐Sánchez, D., Fontecha‐Barriuso, M., Carrasco, S., Sánchez-Niño, M. D., von Mäßenhausen, A., Linkermann, A., Cannata‐Ortiz, P., Ruiz‐Ortega, M., Egido, J., Ortíz, A., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1716578115 · Cited by 156
Self-citationAlterations of PPARalpha and its coactivator PGC-1 in cisplatin-induced acute renal failure
Portilla, D., Dai, G., McClure, T., Bates, L. M., Kurten, R. C., Megyesi, J. K., Price, P. M., & Li, S. (2002) · Kidney International · doi:10.1111/j.1523-1755.2002.kid553.x · Cited by 155
Coll, T., Jové, M., Rodríguez‐Calvo, R., Eyre, E., Palomer, X., Sánchez, R. M., Merlos, M., Laguna, J. C., & Vázquez‐Carrera, M. (2006) · Diabetes · doi:10.2337/db05-1494 · Cited by 152
Suppressed mitochondrial biogenesis in folic acid-induced acute kidney injury and early fibrosis
Stallons, L. J., Whitaker, R. M., & Schnellmann, R. G. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.11.014 · Cited by 150
Formoterol Restores Mitochondrial and Renal Function after Ischemia-Reperfusion Injury
Jesinkey, S. R., Funk, J. A., Stallons, L. J., Wills, L. P., Megyesi, J. K., Beeson, C., & Schnellmann, R. G. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013090952 · Cited by 149
Oh, G., Kim, H., Choi, J.-H., Shen, A., Choe, S., Karna, A., Lee, S., Jo, H.-J., Yang, S., Kwak, T. H., et al. (2013) · Kidney International · doi:10.1038/ki.2013.330 · Cited by 148
Speckmann, B., Walter, P. L., Alili, L., Reinehr, R., Sies, H., Klotz, L., & Steinbrenner, H. (2008) · Hepatology · doi:10.1002/hep.22526 · Cited by 144
Suppression of β Cell Energy Metabolism and Insulin Release by PGC-1α
Yoon, J. C., Xu, G., Deeney, J. T., Yang, S.-N., Rhee, J., Puigserver, P., Levens, A. R., Yang, R., Zhang, C.-Y., Lowell, B. B., et al. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00170-9 · Cited by 143
Whaley‐Connell, A. T., & Sowers, J. R. (2017) · Kidney International · doi:10.1016/j.kint.2016.12.034 · Cited by 143
Targeting epigenetic DNA and histone modifications to treat kidney disease
Fontecha‐Barriuso, M., Martín‐Sánchez, D., Ruiz‐Andrés, O., Poveda, J., Sánchez-Niño, M. D., Rivas, L. V., Ruiz‐Ortega, M., Ortíz, A., & Sanz, A. B. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy009 · Cited by 143
Self-citationRuiz‐Andrés, O., Suárez-Álvarez, B., Sánchez‐Ramos, C., Monsalve, M., Sánchez-Niño, M. D., Ruiz‐Ortega, M., Egido, J., Ortíz, A., & Sanz, A. B. (2015) · Kidney International · doi:10.1038/ki.2015.332 · Cited by 140
Self-citationTan, A. L. Y., Sourris, K. C., Harcourt, B. E., Thallas‐Bonke, V., Penfold, S. A., Andrikopoulos, S., Thomas, M. C., O’Brien, R. C., Bierhaus, A., Cooper, M. E., et al. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00591.2009 · Cited by 132
Heidari, R., Ahmadi, A., Mohammadi, H., Ommati, M. M., Azarpira, N., & Niknahad, H. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.050 · Cited by 131
Rap1 Ameliorates Renal Tubular Injury in Diabetic Nephropathy
Xiao, L., Zhu, X., Yang, S., Liu, F., Zhou, Z., Zhan, M., Xie, P., Zhang, D., Li, J., Song, P., et al. (2013) · Diabetes · doi:10.2337/db13-1412 · Cited by 129
Fenofibrate Improves Renal Lipotoxicity through Activation of AMPK-PGC-1α in db/db Mice
Hong, Y. A., Lim, J. H., Kim, M. Y., Kim, T. W., Kim, Y., Yang, K. S., Park, H. S., Choi, S. R., Chung, S., Kim, H. W., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096147 · Cited by 128
Ge, Q., Huang, C., Zhu, X., Bian, F., & Pan, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173292 · Cited by 128
Zsengellér, Z. K., Ellezian, L., Brown, D. A., Horváth, B., Mukhopadhyay, P., Kalyanaraman, B., Parikh, S. M., Karumanchi, S. A., Stillman, I. E., & Pacher, P. (2012) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155412446227 · Cited by 125
Clinical management of the uraemic syndrome in chronic kidney disease
Vanholder, R., Fouque, D. P., Glorieux, G., Heine, G. H., Kanbay, M., Mallamaci, F., Massy, Z. A., Ortíz, A., Rossignol, P., Więcek, A., et al. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)00033-4 · Cited by 125
The Role of Peroxisome Proliferator-Activated Receptor γ Coactivator 1α (PGC-1α) in Kidney Disease
Li, S., & Suszták, K. (2018) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2018.01.003 · Cited by 123
TWEAK and the progression of renal disease: clinical translation
Sanz, A. B., Izquierdo, M. C., Sánchez-Niño, M. D., Ucero, A. C., Egido, J., Ruiz‐Ortega, M., Ramos, A. M., Putterman, C., & Ortíz, A. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft342 · Cited by 111
Self-citationPyruvate dehydrogenase kinase 4 deficiency attenuates cisplatin-induced acute kidney injury
Oh, C. J., Ha, C., Choi, Y.-K., Park, S., Choe, M. S., Jeoung, N. H., Huh, Y. H., Kim, H.-J., Kweon, H., Lee, J.-M., et al. (2016) · Kidney International · doi:10.1016/j.kint.2016.10.011 · Cited by 107
Augmenting Autophagy to Treat Acute Kidney Injury during Endotoxemia in Mice
Howell, G. M., Gomez, H., Collage, R. D., Loughran, P., Zhang, X., Escobar, D. A., Billiar, T. R., Zuckerbraun, B. S., & Rosengart, M. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069520 · Cited by 105
Fontecha‐Barriuso, M., Martín‐Sánchez, D., Martinez-Moreno, J. M., Carrasco, S., Ruiz‐Andrés, O., Monsalve, M., Sánchez‐Ramos, C., Gómez, M. J., Ruiz‐Ortega, M., Sánchez-Niño, M. D., et al. (2019) · The Journal of Pathology · doi:10.1002/path.5282 · Cited by 105
Self-citationGalloway, C. A., Lee, H., Nejjar, S., Jhun, B. S., Yu, T., Hsu, W., & Yoon, Y. (2012) · Diabetes · doi:10.2337/db11-1640 · Cited by 99
Mitochondria-targeted therapies for acute kidney injury
Tábara, L. C., Poveda, J., Martín-Cleary, C., Selgas, R., Ortíz, A., & Sánchez-Niño, M. D. (2014) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2014.14 · Cited by 97
Whitaker, R. M., Wills, L. P., Stallons, L. J., & Schnellmann, R. G. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.208017 · Cited by 97
Renal tubular involvement mimicking Bartter syndrome in a patient with Kearns-Sayre syndrome
Goto, Y., Itami, N., Kajii, N., Tochimaru, H., Endo, M., & Horai, S. (1990) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80648-1 · Cited by 95
Mitochondrial alterations in cisplatin-induced acute renal failure
Gordon, J. A., & Gattone, V. H. (1986) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1986.250.6.f991 · Cited by 95
Ortíz, A., Sánchez-Niño, M. D., Crespo, M., De-Sequera-Ortiz, P., Fernández-Giráldez, E., Maset, R. G., Macía-Heras, M., Fontán, M. P., Rodríguez, M., Salgueira-Lazo, M., et al. (2018) · Nefrología · doi:10.1016/j.nefro.2018.09.002 · Cited by 95
Li, D., Wang, C., Ma, P., Yu, Q., Gu, M., Dong, L., Jiang, W., Pan, S., Xie, C., Han, J., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0494-0 · Cited by 88
Lemecha, M., Morino, K., Imamura, T., Iwasaki, H., Ohashi, N., Ida, S., Sato, D., Sekine, O., Ugi, S., & Maegawa, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-33438-3 · Cited by 88
Mitochondria and reactive oxygen species in renal cancer
Hervouet, É., Simonnet, H., & Godinot, C. (2007) · Biochimie · doi:10.1016/j.biochi.2007.03.010 · Cited by 83
Ahmed, L. A., Shehata, N. I., Abdelkader, N. F., & Khattab, M. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108889 · Cited by 83
Rap1b GTPase Ameliorates Glucose-Induced Mitochondrial Dysfunction
Sun, L., Xie, P., Wada, J., Kashihara, N., Liu, F.-Y., Zhao, Y., Kumar, D., Chugh, S. S., Danesh, F. R., & Kanwar, Y. S. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008030336 · Cited by 81
Li, L., Wang, C., Yang, H., Liu, S., Lu, Y., Fu, P., & Liu, J. (2017) · Molecular BioSystems · doi:10.1039/c7mb00167c · Cited by 80
Khader, A., Yang, W.-L., Kuncewitch, M., Jacob, A., Prince, J. M., Asirvatham, J. R., Nicastro, J. M., Coppa, G. F., & Wang, P. (2014) · Transplantation · doi:10.1097/tp.0000000000000194 · Cited by 79
Li, S., Park, J., Qiu, C., Han, S. H., Palmer, M. B., Arany, Z. P., & Suszták, K. (2017) · JCI Insight · doi:10.1172/jci.insight.92930 · Cited by 78
Hong, Y. A., Lim, J. H., Kim, M. Y., Kim, Y., Park, H. S., Kim, H. W., Choi, B. S., Chang, Y. S., Kim, H. W., Kim, T., et al. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7207 · Cited by 77
Borniquel, S., García-Quintáns, N., Valle, I., Olmos, Y., Wild, B., Martínez‐Granero, F., Soria, E., Lamas, S., & Monsalve, M. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00175-10 · Cited by 76
Self-citationMiR‐9‐5p protects from kidney fibrosis by metabolic reprogramming
Fierro‐Fernández, M., Miguel, V., Márquez‐Expósito, L., Nuevo‐Tapioles, C., Herrero, J. I., Blanco, E. M., Tituaña, J., Castillo, C., Cannata, P., Monsalve, M., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201901599rr · Cited by 76
Self-citationLempiäinen, J., Finckenberg, P., Mervaala, E. E., Sankari, S., Levijoki, J., & Mervaala, E. M. (2013) · Acta Physiologica · doi:10.1111/apha.12120 · Cited by 75
Cui, J., Shi, S., Sun, X., Cai, G., Cui, S., Hong, Q., Chen, X., & Bai, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069720 · Cited by 75
Oh, Y. S., & Jun, H. (2014) · Nutrition and Metabolic Insights · doi:10.4137/nmi.s13589 · Cited by 75
Resveratrol Rescues Kidney Mitochondrial Function Following Hemorrhagic Shock
Wang, H., Guan, Y., Karamercan, M. A., Ye, L., Bhatti, T. R., Becker, L. B., Baur, J. A., & Sims, C. A. (2015) · Shock · doi:10.1097/shk.0000000000000390 · Cited by 74
Smith, J. A., Stallons, L. J., Collier, J. B., Chavin, K. D., & Schnellmann, R. G. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.221085 · Cited by 73
Regulatory circuitry of TWEAK‐Fn14 system and PGC‐1α in skeletal muscle atrophy program
Hindi, S. M., Mishra, V. K., Bhatnagar, S., Tajrishi, M. M., Ogura, Y., Yan, Z., Burkly, L. C., Zheng, T. S., & Kumar, A. (2013) · The FASEB Journal · doi:10.1096/fj.13-242123 · Cited by 72
Pérez, S., Rius‐Pérez, S., Finamor, I., Martí‐Andrés, P., Priéto, I., García-Gómez, R., Monsalve, M., & Sastre, J. (2018) · The Journal of Pathology · doi:10.1002/path.5166 · Cited by 71
Self-citationEpigenetic Modifiers as Potential Therapeutic Targets in Diabetic Kidney Disease
Martinez-Moreno, J. M., Fontecha‐Barriuso, M., Martín‐Sánchez, D., Guerrero‐Mauvecin, J., Gomá-Garcés, E., Fernández‐Fernández, B., Carriazo, S. M., Sánchez-Niño, M. D., Ramos, A. M., Ruiz‐Ortega, M., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114113 · Cited by 71
Self-citationSmall, D. M., Bennett, N. J., Roy, S., Gabrielli, B. G., Johnson, D. W., & Gobe, G. C. (2013) · Nephron Experimental Nephrology · doi:10.1159/000350726 · Cited by 67
Disruption of cytochrome c heme coordination is responsible for mitochondrial injury during ischemia
Birk, A. V., Chao, W. M., Liu, S., Soong, Y., & Szeto, H. H. (2015) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2015.06.006 · Cited by 66
Scutellarin ameliorates nonalcoholic fatty liver disease through the PPARγ/PGC-1α-Nrf2 pathway
Zhang, X., Ji, R., Sun, H., Peng, J., Ma, X., Wang, C., Fu, Y., Bao, L., & Jin, Y. (2018) · Free Radical Research · doi:10.1080/10715762.2017.1422602 · Cited by 66
de Souza, C. T., Gasparetti, A. L., Pereira‐da‐Silva, M., ARAUJO, E. P. D., Carvalheira, J. B. C., Saad, M. J. A., Boschero, A. C., Carneiro, E. M., & Velloso, L. A. (2003) · Diabetologia · doi:10.1007/s00125-003-1222-5 · Cited by 65
Ashabi, G., Ramin, M., Azizi, P., Taslimi, Z., Alamdary, S. Z., Haghparast, A., Ansari, N., Motamedi, F., & Khodagholi, F. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.04.006 · Cited by 65
Tan, M., Tang, C., Zhang, Y., Cheng, Y., Cai, L., Chen, X., Gao, Y., Deng, Y., & Pan, M. (2015) · Free Radical Research · doi:10.3109/10715762.2015.1016020 · Cited by 63
The Role of TLR4 on PGC‐1α‐Mediated Oxidative Stress in Tubular Cell in Diabetic Kidney Disease
Yuan, S., Liu, X., Zhu, X., Qu, Z. Y., Gong, Z., Li, J., Xiao, L., Yuan, Y., Liu, H., Sun, L., et al. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6296802 · Cited by 63
Oropeza, D., Jouvet, N., Bouyakdan, K., Perron, G., Ringuette, L., Philipson, L. H., Kiss, R. S., Poitout, V., Alquier, T., & Estall, J. L. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.08.001 · Cited by 62
Pgc-1α repression and high-fat diet induce age-related macular degeneration-like phenotypes in mice
Zhang, M., Chu, Y., Mowery, J., Konkel, B., Galli, S., Theos, A. C., & Golestaneh, N. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.032698 · Cited by 61
Qi, X., & Wang, J. (2020) · Aging · doi:10.18632/aging.103078 · Cited by 60
Targeting of regulated necrosis in kidney disease
Martín‐Sánchez, D., Poveda, J., Fontecha‐Barriuso, M., Ruiz‐Andrés, O., Sánchez-Niño, M. D., Ruiz‐Ortega, M., Ortíz, A., & Sanz, A. B. (2017) · Nefrología · doi:10.1016/j.nefro.2017.04.004 · Cited by 57
Self-citationPoveda, J., Sanz, A. B., Carrasco, S., Ruiz‐Ortega, M., Cannata‐Ortiz, P., Sánchez-Niño, M. D., & Ortíz, A. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.89 · Cited by 55
Self-citationCell Death Pathways Drive Necroinflammation during Acute Kidney Injury
von Mäßenhausen, A., Tonnus, W., & Linkermann, A. (2018) · The Nephron journals/Nephron journals · doi:10.1159/000490807 · Cited by 55
Honarpisheh, M. M., Desai, J., Marschner, J. A., Weidenbusch, M. J., Lech, M., Vielhauer, V., Anders, H., & Mulay, S. R. (2016) · Bioscience Reports · doi:10.1042/bsr20160336 · Cited by 53
Sun, H., Zhu, X., Zhou, Y., Cai, W., & Qiu, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061097 · Cited by 53
The Notch pathway: a novel therapeutic target for cardiovascular diseases?
Aquila, G., Kostina, A. S., Sega, F. V. D., Shlyakhto, E. V., Kostareva, A. A., Marracino, L., Ferrari, R., Rizzo, P., & Malashicheva, A. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1641198 · Cited by 52
Terada, Y., Inoue, K., Matsumoto, T., Ishihara, M., Hamada, K., Shimamura, Y., Ogata, K., Inoue, K., Taniguchi, Y., Horino, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080850 · Cited by 50
Fedorova, L. V., Sodhi, K., Gatto-Weis, C. M., Puri, N., Hinds, T. D., Shapiro, J. I., & Malhotra, D. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064436 · Cited by 48
Loss of NLRP6 expression increases the severity of acute kidney injury
Rivas, L. V., Cuarental, L., Núñez, G., Sanz, A. B., Ortíz, A., & Sánchez-Niño, M. D. (2019) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfz169 · Cited by 48
Self-citationFree fatty acids increase PGC‐1α expression in isolated rat islets
Zhang, P., Liu, C., Zhang, C., Zhang, Y., Shen, P., Zhang, J., & Zhang, C.-Y. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.01.046 · Cited by 45
Bartz, R. R., Fu, P. P., Suliman, H. B., Crowley, S. D., MacGarvey, N. C., Welty‐Wolf, K. E., & Piantadosi, C. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100912 · Cited by 45
Oxidative stress induces loss of pericyte coverage and vascular instability in PGC-1α-deficient mice
García-Quintáns, N., Sánchez‐Ramos, C., Priéto, I., Tiérrez, A., Arza, E., Alfranca, A., Redondo, J. M., & Monsalve, M. (2016) · Angiogenesis · doi:10.1007/s10456-016-9502-0 · Cited by 45
Self-citationShen, H., Ming, Y., Xu, C., Xu, Y., Zhao, S., & Zhang, Q. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28153 · Cited by 43
Collier, J. B., Whitaker, R. M., Eblen, S. T., & Schnellmann, R. G. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.754762 · Cited by 42
Selenium and selenoproteins: from endothelial cytoprotection to clinical outcomes
Lopes, E., Leite, H. P., & Konstantyner, T. (2019) · Translational research · doi:10.1016/j.trsl.2019.01.004 · Cited by 41
Yao, W., Cai, H., Li, X., Li, T., Hu, L., & Peng, T. (2014) · Journal of Virology · doi:10.1128/jvi.01202-14 · Cited by 39
Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease
Wattacheril, J. J. (2019) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2019.10.002 · Cited by 39
Felder, T. K., Soyal, S. M., Oberkofler, H., Hahne, P., Auer, S., Weiss, R., Gadermaier, G., Miller, K. N., Krempler, F., Esterbauer, H., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.227496 · Cited by 38
SRT1720, a sirtuin 1 activator, attenuates organ injury and inflammation in sepsis
Khader, A., Yang, W.-L., Hansen, L. W., Rajayer, S. R., Prince, J. M., Nicastro, J. M., Coppa, G. F., & Wang, P. (2017) · Journal of Surgical Research · doi:10.1016/j.jss.2017.06.031 · Cited by 37
Linking Metabolic Disease With the PGC-1α Gly482Ser Polymorphism
Vandenbeek, R., Khan, N. P., & Estall, J. L. (2017) · Endocrinology · doi:10.1210/en.2017-00872 · Cited by 37
de Lima, T. I., Araújo, H. N., Menezes, E. S., Sponton, C. H., de Araújo, M. B., Bomfim, L. H. M., Queiroz, A. L., Passos, M. A., Sousa, T. A. E., Hirabara, S. M., et al. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25645 · Cited by 35
Hypoxia-induced PGC-1α Regulates Mitochondrial Function and Tumorigenesis of Colorectal Cancer Cells
Yun, C. W., Lee, J. H., & Lee, S. H. (2019) · Anticancer Research · doi:10.21873/anticanres.13672 · Cited by 35
Regulation of endothelial dynamics by PGC-1α relies on ROS control of VEGF-A signaling
García-Quintáns, N., Priéto, I., Sánchez‐Ramos, C., Luque, A., Arza, E., Olmos, Y., & Monsalve, M. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.01.021 · Cited by 34
Self-citationJankauskas, S. S., Andrianova, N. V., Alieva, I. B., Прусов, А. Н., Matsievsky, D. D., Zorova, L. D., Pevzner, I. B., Savchenko, E. S., Pirogov, Y. A., Silachev, D. N., et al. (2016) · Biochemistry (Moscow) · doi:10.1134/s0006297916120154 · Cited by 34
Wang, X., Tang, D., Zou, Y.-W., Wu, X., Chen, Y., Li, H., Chen, S., Shi, Y., & Niu, H. (2019) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2018.1488697 · Cited by 34
PGC1α Plays a Critical Role in TWEAK–Induced Cardiac Dysfunction
Shi, J., Jiang, B., Qiu, Y., Guan, J., Jain, M., Cao, X., Bauer, M., Su, L., Burkly, L. C., Leone, T. C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054054 · Cited by 33
Goyenechea, E., Crujeiras, A. B., Abete, I., Parra, D., & Martínez, J. A. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.08.011 · Cited by 32
Sánchez‐Ramos, C., Priéto, I., Tiérrez, A., Laso, J., Valdecantos, M. P., Bartrons, R., Roselló‐Catafau, J., & Monsalve, M. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6836 · Cited by 31
Self-citationSuppression of PGC-1alpha by Ethanol: Implications of Its Role in Alcohol Induced Liver Injury.
Chaung, W. W., Jacob, A., Ji, Y., & Wang, P. (2008) · PubMed · Cited by 30
Mitochondrial disorders in renal tumors
Hervouet, É., & Godinot, C. (2006) · Mitochondrion · doi:10.1016/j.mito.2006.03.003 · Cited by 30
PGC-1α overexpression protects against aldosterone-induced podocyte depletion: role of mitochondria
Zhao, M., Yuan, Y., Bai, M., Ding, G., Jia, Z., Huang, S., & Zhang, A. (2016) · Oncotarget · doi:10.18632/oncotarget.7859 · Cited by 27
Longitudinal Study on Mitochondrial Effects of Didanosine–Tenofovir Combination
López, S., Negredo, E., Garrabou, G., Puig, J., Ruiz, L., Sanjurjo, E., Ramos, X., Infante, A. B., Casademont, J., Cardellach, F., et al. (2006) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2006.22.33 · Cited by 26
Short ischemia induces rat kidney mitochondria dysfunction
Banienė, R., Trumbeckas, D., Kinčius, M., Paužienė, N., Raudonė, L., Jievaltas, M., & Trumbeckaitė, S. (2016) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-016-9643-2 · Cited by 19
Zepeda‐Orozco, D., Kong, M., & Scheuermann, R. H. (2015) · Transplantation Proceedings · doi:10.1016/j.transproceed.2015.04.086 · Cited by 16
Kim, J., Sun, C., Jeon, S., You, Y., Shin, J., Lee, S., Cho, J., Park, C., & Yoon, K. (2012) · BMB Reports · doi:10.5483/bmbrep.2012.45.1.51 · Cited by 12
Kim, J.-W., Park, S., You, Y., Ham, D., Park, H., Lee, S., Yang, H. K., & Yoon, K. (2014) · Transplantation · doi:10.1097/01.tp.0000438627.68225.25 · Cited by 11
Mukunyadzi, P., Huang, H., Liu, K., & Fan, C. (2003) · Applied immunohistochemistry & molecular morphology · doi:10.1097/00129039-200312000-00010 · Cited by 7
Current and Emerging Therapies for Mitochondriopathies
Lagler, F. B. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_264 · Cited by 4
Cited by
PGC-1α Is a Master Regulator of Mitochondrial Lifecycle and ROS Stress Response
Abu Shelbayeh, O., Arroum, T., Morris, S., & Busch, K. B. (2023) · Antioxidants · doi:10.3390/antiox12051075 · Cited by 552
Signaling pathways of chronic kidney diseases, implications for therapeutics
Yuan, Q., Tang, B., & Zhang, C. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01036-5 · Cited by 453
Mitochondrial dysfunction: roles in skeletal muscle atrophy
Chen, X., Ji, Y., Liu, R., Zhu, X., Wang, K., Yang, X., Liu, B., Gao, Z., Huang, Y., Shen, Y., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04369-z · Cited by 317
Mitochondria: It is all about energy
Casanova, A., Wevers, A., Navarro-Ledesma, S., & Pruimboom, L. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1114231 · Cited by 303
Oxidative Stress and Mitochondrial Dysfunction in Chronic Kidney Disease
Ho, H.-J., & Shirakawa, H. (2022) · Cells · doi:10.3390/cells12010088 · Cited by 255
Metadata
- Authors
- Fontecha-Barriuso, M., Martin-Sanchez, D., Martinez-Moreno, J., Monsalve, M., Ramos, A., Sanchez-Niño, M., Ruiz-Ortega, M., Ortiz, A., & Sanz, A.
- Venue
- Biomolecules
- Publisher
- MDPI AG
- Published
- 2020-02-24
- Volume
- 10
- Issue
- 2
- Pages
- 347
- ISSN
- 2218-273X (ISSN-L)
- OpenAlex
- W3008307436
- Cited by
- 294
- References
- 188
- FWCI
- 14.92
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.